Recombinant Human GHRH (C-Fc)
Recombinant Human GHRH (C-Fc) from ELK Biotechnology Read more ›
Product Description
Recombinant Human GHRH (C-Fc) is an ELK Biotechnology recombinant protein for research use.
Description
Recombinant Human Growth Hormone-releasing Factor is produced by our Mammalian expression system and the target gene encoding Pro21-Leu75 is expressed with a Fc tag at the C-terminus.
Background
Growth-hormone-releasing hormone (GHRH) is a releasing hormone for growth hormone. It is a 44-amino acid peptide hormone produced in the arcuate nucleus of the hypothalamus. GHRH first appears in the human hypothalamus between 18 and 29 weeks of gestation, which corresponds to the start of production of growth hormone and other somatotropes in fetuses. GRF is released by the hypothalamus and acts on the adenohypophyse to stimulate the secretion of growth hormone.
Handling information
| Reconstitution | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100µg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
|---|---|
| Delivery condition | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature listed below. |
Key Facts
| Target | GHRH |
| Also known as | Somatoliberin; Growth hormone-releasing factor; Somatocrinin; Somatorelin; Growth hormone-releasing hormone; GHRH; GHRF |
| Purity | Greater than 95% as determined by reducing SDS-PAGE. |
| Form / buffer | Lyophilized protein |
| Research area | Molecular Biology |
| Specification | PURITY | ENDOTOXIN | BIOACTIVITY |
|---|---|---|---|
| Product QC |
Specifications
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Not intended for diagnostic or therapeutic use.